Because we see it day-in and day-out, we tend to overlook it. And yet, it's a fascinating disease, and apart antibiotics/vaccines, anti-hypertensives are the single most important therapy contributing to rising life expectancies. As such, if there is one disease to know, and know well, it's hypertension. But management is more nuanced than following the national guidelines and prescribing the same handful of agents. It's about understanding the natural history, appreciating differences among agents in the same class, and tailoring blood pressure targets to each patient.
I've created this free, bi-weekly e-newsletter as a non-commercial medium to convey key aspects of the disease to other physicians. Each issue is concise, summarizing one seminal paper and underscoring one key concept. Every newsletter ends with a "clinical perspective" that will change the management of the next case you see.
Hillel Sternlicht, M.D., FASN ASH Designated Hypertension Specialist Assistant Professor of Medicine (Nephrology) Lenox Hill Hospital-Hofstra University School of Medicine New York, New York
Email me with questions Or Via Twitter: @ConceptsInHTN
After attending the University of Virginia School of Medicine, I completed my internal medicine residency at Albert Einstein/Montefiore Medical Center in New York. I trained in Nephrology at New-York Presbyterian-Weill Cornell Medical Center and Memorial Sloan-Kettering Cancer Center. I completed a second fellowship in hypertension under George Bakris at the University of Chicago's American Society of Hypertension-Designed Comprehensive Hypertension Center; I am an ASH certified hypertension specialist and currently an Assistant Professor of Medicine (Nephrology) at Lenox Hill Hospital in New York City.
Privacy + Disclosures
-I appreciate your interest and will not release your email to any third party -I have no commercial ties and intend for the newsletter to be a strictly educational endeavor